Replimune Group Inc (REPL)
10.80
-0.60
(-5.26%)
USD |
NASDAQ |
Nov 15, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Enterprise Value: 352.42M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 352.42M |
| November 14, 2024 | 393.47M |
| November 13, 2024 | 413.31M |
| November 12, 2024 | 447.52M |
| November 11, 2024 | 468.73M |
| November 08, 2024 | 464.63M |
| November 07, 2024 | 448.61M |
| November 06, 2024 | 482.12M |
| November 05, 2024 | 435.62M |
| November 04, 2024 | 435.62M |
| November 01, 2024 | 427.41M |
| October 31, 2024 | 417.83M |
| October 30, 2024 | 441.77M |
| October 29, 2024 | 453.40M |
| October 28, 2024 | 437.67M |
| October 25, 2024 | 415.78M |
| October 24, 2024 | 431.51M |
| October 23, 2024 | 434.93M |
| October 22, 2024 | 432.20M |
| October 21, 2024 | 389.79M |
| October 18, 2024 | 402.10M |
| October 17, 2024 | 387.06M |
| October 16, 2024 | 393.90M |
| October 15, 2024 | 334.39M |
| October 14, 2024 | 343.28M |
| Date | Value |
|---|---|
| October 11, 2024 | 398.68M |
| October 10, 2024 | 374.06M |
| October 09, 2024 | 419.20M |
| October 08, 2024 | 416.47M |
| October 07, 2024 | 388.42M |
| October 04, 2024 | 404.15M |
| October 03, 2024 | 413.05M |
| October 02, 2024 | 452.71M |
| October 01, 2024 | 427.41M |
| September 30, 2024 | 363.12M |
| September 27, 2024 | 338.53M |
| September 26, 2024 | 336.49M |
| September 25, 2024 | 332.39M |
| September 24, 2024 | 332.39M |
| September 23, 2024 | 324.87M |
| September 20, 2024 | 321.45M |
| September 19, 2024 | 343.32M |
| September 18, 2024 | 333.07M |
| September 17, 2024 | 329.65M |
| September 16, 2024 | 290.71M |
| September 13, 2024 | 336.49M |
| September 12, 2024 | 285.24M |
| September 11, 2024 | 284.56M |
| September 10, 2024 | 282.51M |
| September 09, 2024 | 295.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-68.95M
Minimum
Dec 05 2023
2.185B
Maximum
Dec 01 2020
634.98M
Average
549.33M
Median
Enterprise Value Benchmarks
| Bristol-Myers Squibb Co | 155.74B |
| Nuvalent Inc | 5.005B |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
| iBio Inc | 6.468M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -53.06M |
| Total Expenses (Quarterly) | 58.51M |
| EPS Diluted (Quarterly) | -0.68 |
| Earnings Yield | -28.24% |